What is the annual revenue of Alnylam Sweden AB?

The Alnylam Sweden AB annual revenue is 100–500M SEK.

How many people are employed at Alnylam Sweden AB?

5–9 people are employed at Alnylam Sweden AB.

Where is Alnylam Sweden AB based?

Alnylam Sweden AB is based in STOCKHOLM, Sweden.

When was Alnylam Sweden AB founded?

Alnylam Sweden AB was founded in 2016.

What industry is Alnylam Sweden AB in?

Alnylam Sweden AB operates in the Partihandel med medicinsk utrustning och apoteksvaror industry.

What is Alnylam Sweden AB's website?

You can visit Alnylam Sweden AB's website at https://www.alnylam.se.

Alnylam Sweden AB

559086-6686Active

Leading RNAi therapeutics company developing gene-silencing medicines.

Biopharmaceutical Companyalnylam.se

5–9
Employees: 100–500M SEK
Revenue: 2016
Founded

Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...

Keywords

BiopharmaBiotechnologyDrug DevelopmentGene SilencingRare DiseasesRNAi TherapeuticsTherapeutics Pipeline

Decision Makers

No decision makers found yet

Similar Companies

20 similar companies in Funnelfeedr

Alexion Pharma Nordics AB

10–19 employees

Pioneering transformative medicines for the global rare disease community.

Purpose Pharma International AB

5–9 employees

Developing and supplying rare disease treatments across Europe.

PTC Therapeutics Sweden AB

Developing transformative treatments for rare diseases globally for patients.

ASTRAZENECA PLC

Global science-led pharmaceutical business developing life-changing medicines.

ScandiBio Therapeutics AB

0 employees

AI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.

Browse More

Top Technology companies in Sweden Top Pharmaceuticals companies in Sweden Top HealthTech companies in Sweden